Cleveland Clinic research shows that copays for enoxaparin prophylaxis are relatively small for most insured patients. The findings should ease cost concerns that might inhibit using the therapy to prevent blood clots following inflammatory bowel disease surgery.
Low-Dose Aspirin for Extended VTE Prophylaxis After IBD Surgery
Venous thromboembolism extended prophylaxis with low-dose aspirin after inflammatory bowel disease surgery is a safe and cost-effective strategy when compared with enoxaparin or no prophylaxis.
Venous Thromboembolism Common in Cancer Patients Treated with Immunotherapy
Venous thromboembolism occurs in up to 25% of cancer patients treated with immunotherapy, according to a recent Cleveland Clinic study.
Managing Thrombotic Complications in ICU Patients with COVID-19
Venous thromboembolism is markedly higher in patients with COVID-19 in the intensive care unit, but routine screening is not recommended. Shruti Gadre, MD, discusses when to consider testing and how to manage care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Thrombotic Complications of COVID-19: Principles for Treatment and Prevention
Severe COVID-19 is associated with a hypercoagulable state that often requires changes to usual inpatient anticoagulation strategies. We share our approach, including thromboprophylaxis protocols and a case vignette.
Efforts Underway to Decrease Preventable Maternal Morbidity and Mortality
Three in five pregnancy-related deaths in the United States are preventable. Cleveland Clinic obstetrician, Kathleen Berkowitz, MD, explains the protocols the health system has put in place to prevent maternal mortality and respond to obstetric emergencies.
Rivaroxaban Reduces VTE in Patients with Pancreatic Cancer
A secondary analysis of the CASSINI trial finds that rivaroxaban is an effective thromboprophylactic for patients with pancreatic cancer receiving systemic therapy.
Oral Anticoagulants Show Benefit for Cancer Patients at High Risk of Venous Thromboembolism
Two new studies show that oral anticoagulants and prescreening for blood clots before starting cancer treatment may help prevent blood clots in high-risk cancer patients.
The Khorana Score 10 Years Later
Since Alok Khorana, MD, introduced this tool a decade ago, it has been validated multiple times in different countries and incorporated into a number of society guidelines.
Nurse-led Study Examines the Effectiveness of Patient Education Plans on VTE Knowledge
Post-operative VTEs can be deadly. A nurse-led study at Cleveland Clinic compared the effectiveness of written instructions versus a multimethod educational approach to teach patients about VTEs.